| Ytd | -30.35% | |
| 1y | 9.84% |
| Open | 8.02 | Prev Close | 8.02 | Low | 7.96 | High | 8.29 | Mkt Cap | 532.95M |
| Vol | 625.54K | Avg Vol | 819.42K | EPS | -3.32 | P/E | -2.49 | Forward P/E | -1.78 |
| Beta | 1.74 | Short Ratio | 11.90 | Inst. Own | 110.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.32 | 200-d Avg | 10.70 | 1yr Est | 58.55 |
ARVN News
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hemat
Stephens & Co. analyst Sudan Loganathan reiterates Arvinas (NASDAQ:ARVN) with a Overweight an
Following a strategic review of its pipeline, the Company has made the decision to re-prioritize its
Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Phar
Barclays analyst Etzer Darout maintains Arvinas (NASDAQ:ARVN) with a Overweight and raises the pr
Top Wall Street analysts updated their ratings on top companies. For full list of changes, including
BTIG analyst Jeet Mukherjee maintains Arvinas (NASDAQ:ARVN) with a Buy and raises the price targ
Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer fol
Arvinas, Inc. (NASDAQ:ARVN), a biotechnology company creating a new class of drugs based on targeted
Arvinas (NASDAQ:ARVN) reported quarterly losses of $(0.90) per share which missed the analyst consen
On Wednesday, 311 stocks hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During Wednesday's session, 212 companies made new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Gainers